A Study of AK101 in Subjects With Moderately to Severely Active Ulcerative Colitis
NCT06281704
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
34
Enrollment
INDUSTRY
Sponsor class
Conditions
Ulcerative Colitis
Interventions
BIOLOGICAL:
AK101 IV
BIOLOGICAL:
AK101 SC
BIOLOGICAL:
Placebo
BIOLOGICAL:
AK101 IV/AK101 SC
Sponsor
Akeso